leading to hyperphosphatemia (elevated phosphate levels in the blood), a common adverse event associated with FGFR inhibitors. FGFR2 inhibition: Causes dermatologic adverse events, including nail ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback